Xcout IntelVitranu, Inc.
Vitranu, Inc. is a biopharmaceutical and biochemical technology company developing an innovative ophthalmic drug, with its corporate office located in Columbus, Ohio.
Subscribe to see Vitranu, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Vitranu, Inc. at a glance
Vitranu, Inc. is a company headquartered in United States. Its most recent funding round raised $1.5M in October 2021. Xcout tracks 5 named people at Vitranu, Inc., including John Black (CEO).
Vitranu, Inc. leadership
- John BlackCEO
- Katelyn Swindle-ReillyChief Technology Officer
- Joe Seiwert IIIChief Product Development Officer
- Matthew OhrChief Medical Officer, Medical Advisory Board member
- Brian PriceDirector CMC
Vitranu, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1.5M | — | |
| — | $3M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Vitranu, Inc. competitors
A few of Vitranu, Inc.'s closest competitors — see the full list of competitors and alternatives →
Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing transformative therapies and products for eye disorders.
OcuTerra Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Boston, Massachusetts. The company focuses on developing new therapeutic drugs and treatments for eye diseases.
Ocunexus Therapeutics, Inc. is a biotechnology company founded in 2005 and headquartered in San Diego, California, specializing in therapeutic solutions for ocular conditions.
DNA Nanobots, LLC is a biotechnology company founded in Columbus, Ohio, that develops products for targeted therapeutics and functionalized gene delivery.
Surface Ophthalmics, Inc. is a pharmaceutical company dedicated to developing and commercializing innovative therapeutics for the treatment of ocular diseases.
Get Vitranu, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Vitranu, Inc.? Suggest a correction · Work at Vitranu, Inc.? Claim this profile
Is this your company? Add the Xcout Intel badge to your website
Free, for any company on Xcout Intel. It links visitors to this profile.
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Vitranu, Inc. in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access